Engineers inspected and analyzed the returned device.The ipg was confirmed to have reached end of service eos state.The device was in service for a total of 4 months and 12 days with an average energy use index eui of 93.7 which confirmed high energy consumption use.The device longevity was within the expected range based on the eui measurement.Premature battery depletion was not confirmed.The device exhibited normal characteristics.A product labeling review identified that the device was used per the instructions for use ifu product label.Additionally, it states, when the stimulator battery is fully depleted, the end of service eos indicator will be displayed on the remote control and clinician programmer.Stimulation will not be available.Surgery is required to replace the implanted non rechargeable stimulator to continue providing stimulation.The longevity of the non rechargeable stimulator battery depends on the following factors, programmed parameters, system impedance, hours per day of stimulation, changes to stimulation made by the patient.Dystonia may be triggered by the loss of dbs therapy as well as by other factors and may lead to respiratory distress or failure, rhabdomyolysis, multiorgan failure, and death.Ensure that patients and caregivers understand the importance of maintaining dbs therapy and that its loss for any reason, accidental turnoff, battery depletion, and system failure could cause symptom return and are a known risks with the use of deep brain stimulation.
|